Patrys Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Patrys
- Completion of Acquisition and Board Appointments
- Pipeline Expanded with Proprietary Injectable Antipsychotic
- Trading Halt
- Appendix 4C - Quarterly - 30 September 2025
- Patrys Receives R&D Tax Incentive Refund
Later from Patrys
- Appendix 4C - Quarterly - 31 December 2025
- Appointment of Chief Executive Officer
- Appendix 4D - Half Year Accounts - 31 December 2025
- RLS-2201 Manufacturing and Regulatory Pathway Initiated
- Investor Presentation - Broker Meets Biotech
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys